Subscribe to RSS

DOI: 10.1055/a-2802-3753
Clinical Heterogeneity and Prognostic Impact of Disseminated Intravascular Coagulation in Critically Ill Patients: A Large-Scale Retrospective Study
Authors

Abstract
Background
Disseminated intravascular coagulation (DIC) is a serious condition characterized by systemic coagulation activation leading to thrombotic and hemorrhagic complications. Although the characteristics of DIC vary depending on the underlying cause, studies directly comparing coagulation/fibrinolysis laboratory findings across a wide range of underlying diseases are limited.
Objective
We investigated the characteristics of coagulation/fibrinolysis laboratory results, the frequency of DIC, and the impact of DIC on patient prognosis across various underlying diseases in a critical care setting.
Methods
This was a single-center retrospective observational study of 1,665 critically ill patients admitted between January 1, 2010, and December 21, 2022. Patients were categorized based on underlying diseases, which included out-of-hospital cardiac arrest, sepsis, trauma, burn, and heat stroke. We retrospectively collected data on background, DIC scores, laboratory results, and in-hospital mortality rates of patients.
Results
Significant heterogeneity in coagulation/fibrinolysis laboratory findings was observed, with all findings differing based on the underlying disease (p < 0.001). For example, patients with trauma-associated DIC showed significantly elevated D-dimer and fibrin/fibrinogen degradation product levels, while those with burn-associated DIC tended to have high platelet counts and a rapid decrease in antithrombin activity following admission. Among all underlying diseases, the development of DIC was associated with an increase in in-hospital mortality. This association was particularly strong in patients with trauma or burns.
Conclusion
The coagulation/fibrinolysis laboratory findings, along with the clinical trajectory of DIC, exhibit remarkable heterogeneity depending on the precipitating cause. Development of DIC in patients with burn or trauma is strongly associated with increased in-hospital mortality.
Ethical Approval
This study was approved by the Institutional Review Board of the Ethics Committee of Hokkaido University Hospital (no. 024-0247, approved November 12, 2024) and was conducted in accordance with the Declaration of Helsinki. The need for written informed consent was waived because of the retrospective design of the study.
Publication History
Received: 06 October 2025
Accepted: 31 January 2026
Article published online:
12 February 2026
© 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Levi M, Sivapalaratnam S. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Expert Rev Hematol 2018; 11 (08) 663-672
- 2 Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 1999; 82 (02) 695-705
- 3 Iba T, Levi M, Thachil J, Levy JH. Disseminated intravascular coagulation: the past, present, and future considerations. Semin Thromb Hemost 2022; 48 (08) 978-987
- 4 Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. J Intensive Care 2025; 13 (01) 32
- 5 Iba T, Levy JH, Maier CL. et al. Updated definition and scoring of disseminated intravascular coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation. J Thromb Haemost 2025; 23 (07) 2356-2362
- 6 Wada T, Gando S. Phenotypes of disseminated intravascular coagulation. Thromb Haemost 2024; 124 (03) 181-191
- 7 Asakura H. Classifying types of disseminated intravascular coagulation: clinical and animal models. J Intensive Care 2014; 2 (01) 20
- 8 Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 1990; 33 (02) 90-95
- 9 Kawasugi K, Wada H, Hatada T. et al; Japanese Society of Thrombosis Hemostasis/DIC Subcommittee. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases. Thromb Res 2011; 128 (02) 186-190
- 10 Asakura H, Ontachi Y, Mizutani T. et al. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Crit Care Med 2001; 29 (06) 1164-1168
- 11 Ohbe H, Yamakawa K, Taniguchi K. et al. Underlying disorders, clinical phenotypes, and treatment diversity among patients with disseminated intravascular coagulation. JMA J 2020; 3 (04) 321-329
- 12 Bone RC, Balk RA, Cerra FB. et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101 (06) 1644-1655
- 13 Levy MM, Fink MP, Marshall JC. et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2001; 2003: 31
- 14 Baker SP, O'Neill B, Haddon Jr W, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 1974; 14 (03) 187-196
- 15 Gando S, Saitoh D, Ogura H. et al; Japanese Association for Acute Medicine Disseminated Intravascular Coagulation (JAAM DIC) Study Group. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med 2008; 36 (01) 145-150
- 16 Aibiki M, Fukuoka N, Umakoshi K, Ohtsubo S, Kikuchi S. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation. Shock 2007; 27 (02) 139-144
- 17 Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood 2019; 133 (06) 511-520
- 18 Hayakawa M. Pathophysiology of trauma-induced coagulopathy: disseminated intravascular coagulation with the fibrinolytic phenotype. J Intensive Care 2017; 5: 14
- 19 Hayakawa M, Gando S, Ono Y, Wada T, Yanagida Y, Sawamura A. Fibrinogen level deteriorates before other routine coagulation parameters and massive transfusion in the early phase of severe trauma: a retrospective observational study. Semin Thromb Hemost 2015; 41 (01) 35-42
- 20 Lavrentieva A, Kontakiotis T, Bitzani M. et al. Early coagulation disorders after severe burn injury: impact on mortality. Intensive Care Med 2008; 34 (04) 700-706
- 21 Lippi G, Ippolito L, Cervellin G. Disseminated intravascular coagulation in burn injury. Semin Thromb Hemost 2010; 36 (04) 429-436
- 22 Zhang TN, Ba T, Li F. et al. Coagulation dysfunction of severe burn patients: a potential cause of death. Burns 2023; 49 (03) 678-687
- 23 Cato LD, Wearn CM, Bishop JRB, Stone MJ, Harrison P, Moiemen N. Platelet count: a predictor of sepsis and mortality in severe burns. Burns 2018; 44 (02) 288-297
- 24 Niedermayr M, Schramm W, Kamolz L. et al. Antithrombin deficiency and its relationship to severe burns. Burns 2007; 33 (02) 173-178
- 25 Osuka A, Ishihara T, Shimizu K, Shintani A, Ogura H, Ueyama M. Natural kinetics of blood cells following major burn: impact of early decreases in white blood cells and platelets as prognostic markers of mortality. Burns 2019; 45 (08) 1901-1907
- 26 Rohrer MJ, Natale AM. Effect of hypothermia on the coagulation cascade. Crit Care Med 1992; 20 (10) 1402-1405
- 27 Wallner B, Schenk B, Hermann M. et al. Hypothermia-associated coagulopathy: a comparison of viscoelastic monitoring, platelet function, and real time live confocal microscopy at low blood temperatures, an in vitro experimental study. Front Physiol 2020; 11: 843
- 28 Lindenblatt N, Menger MD, Klar E, Vollmar B. Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol Heart Circ Physiol 2005; 289 (06) H2680-H2687
- 29 Matsuyama T, Morita S, Ehara N. et al. Characteristics and outcomes of accidental hypothermia in Japan: the J-point registry. Emerg Med J 2018; 35 (11) 659-666
- 30 Fujimoto Y, Matsuyama T, Morita S. et al. Indoor versus outdoor occurrence in mortality of accidental hypothermia in Japan: the J-point registry. Ther Hypothermia Temp Manag 2020; 10 (03) 159-164
- 31 Kobayashi T, Mikami R, Hayakawa M. Association between recombinant human soluble thrombomodulin administration dosages and mortality in patients with sepsis-induced disseminated intravascular coagulation. Thromb J 2025; 23 (01) 101
- 32 Iba T, Saitoh D, Wada H, Asakura H. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey. Crit Care 2014; 18 (05) 497
- 33 Hayakawa M, Tsuchida T, Honma Y. et al. Fibrinolytic system activation immediately following trauma was quickly and intensely suppressed in a rat model of severe blunt trauma. Sci Rep 2021; 11 (01) 20283
- 34 Gando S, Hayakawa M. Pathophysiology of trauma-induced coagulopathy and management of critical bleeding requiring massive transfusion. Semin Thromb Hemost 2016; 42 (02) 155-165
- 35 Hayakawa M, Kudo D, Saito S. et al. Antithrombin supplementation and mortality in sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study. Shock 2016; 46 (06) 623-631
- 36 Hayakawa M, Yamakawa K, Saito S. et al; Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost 2016; 115 (06) 1157-1166
- 37 Takahashi Y, Hayakawa M, Itagaki Y, Ono K, Kudo D, Kushimoto S. Coagulopathy as a predictor of the effectiveness of tranexamic acid in severe blunt trauma: a multicenter retrospective study. Thromb J 2025; 23 (01) 37
- 38 Yamakawa K, Okamoto K, Seki Y. et al; Committee of the Clinical Practice Guidelines for Management of Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis and Hemostasis. Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis. Int J Hematol 2025; 121 (05) 592-604
- 39 Hayakawa M, Seki Y, Ikezoe T. et al; Committee of the Clinical Practice Guidelines for Disseminated Intravascular Coagulation 2024, the Japanese Society on Thrombosis, Hemostasis. Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024: part 4-trauma, burn, obstetrics, acute pancreatitis/liver failure, and others. Int J Hematol 2025; 121 (05) 633-652
- 40 Cohen J. Statistical Power Analysis for the Behavioural Sciences, 2nd Edn. Hillside, NJ: Lawrence Erlbaum Associates; 1988. : pp. 25-27